AAAAAA

   
Results: 1-25 | 26-40
Results: 1-25/40

Authors: KOREN MJ SMITH DG HUNNINGHAKE DB DAVIDSON MH MCKENNEY JM WEISS SR SCHROTT HG HENLEY RW TRESH P MCLAIN RW BAKKERARKEMA RG BLACK DM
Citation: Mj. Koren et al., THE COST OF REACHING NATIONAL-CHOLESTEROL-EDUCATION-PROGRAM (NCEP) GOALS IN HYPERCHOLESTEROLEMIC PATIENTS - A COMPARISON OF ATORVASTATIN, SIMVASTATIN, LOVASTATIN AND FLUVASTATIN, PharmacoEconomics, 14(1), 1998, pp. 59-70

Authors: HOLLANDER PA ELBEIN SC HIRSCH IB KELLEY D MCGILL J TAYLOR T WEISS SR CROCKETT SE KAPLAN RA COMSTOCK J LUCAS CP LODEWICK PA CANOVATCHEL W CHUNG J HAUPTMAN J
Citation: Pa. Hollander et al., ROLE OF ORLISTAT IN THE TREATMENT OF OBESE PATIENTS WITH TYPE-2 DIABETES - A 1-YEAR RANDOMIZED DOUBLE-BLIND-STUDY, Diabetes care, 21(8), 1998, pp. 1288-1294

Authors: WEISS SR COPPOLA J GAMBINO J NAHAL A
Citation: Sr. Weiss et al., ISOLATED ACUTE PAPILLARY-MUSCLE INFARCTION IN THE ABSENCE OF CORONARY-ARTERY DISEASE RESULTING IN CARDIOGENIC-SHOCK AND EMERGENT MITRAL-VALVE REPLACEMENT, Catheterization and cardiovascular diagnosis, 43(2), 1998, pp. 185-189

Authors: LUO ZL WEISS SR
Citation: Zl. Luo et Sr. Weiss, ROLES IN CELL-TO-CELL FUSION OF 2 CONSERVED HYDROPHOBIC REGIONS IN THE MURINE CORONAVIRUS SPIKE PROTEIN, Virology, 244(2), 1998, pp. 483-494

Authors: HINGLEY ST LEPARCGOFFART I WEISS SR
Citation: St. Hingley et al., THE SPIKE PROTEIN OF MURINE CORONAVIRUS MOUSE HEPATITIS-VIRUS STRAIN A59 IS NOT CLEAVED IN PRIMARY GLIAL-CELLS AND PRIMARY HEPATOCYTES, Journal of virology, 72(2), 1998, pp. 1606-1609

Authors: LEPARCGOFFART I HINGLEY ST CHUA MM PHILLIPS J LAVI E WEISS SR
Citation: I. Leparcgoffart et al., TARGETED RECOMBINATION WITHIN THE SPIKE GENE OF MURINE CORONAVIRUS MOUSE HEPATITIS VIRUS-A59 - Q159 IS A DETERMINANT OF HEPATOTROPISM, Journal of virology (Print), 72(12), 1998, pp. 9628-9636

Authors: WEISS SR MCFARLAND BH BURKHART GA HO PTC
Citation: Sr. Weiss et al., CANCER RECURRENCES AND 2ND PRIMARY CANCERS AFTER USE OF ANTIHISTAMINES OR ANTIDEPRESSANTS, Clinical pharmacology and therapeutics, 63(5), 1998, pp. 594-599

Authors: STEIN EA DAVIDSON MH DOBS AS SCHROTT H DUJOVNE CA BAYS H WEISS SR MELINO MR STEPANAVAGE ME MITCHEL YB
Citation: Ea. Stein et al., EFFICACY AND SAFETY OF SIMVASTATIN 80 MG DAY IN HYPERCHOLESTEROLEMIC PATIENTS/, The American journal of cardiology, 82(3), 1998, pp. 311-316

Authors: SUTHERLAND RM CHUA MM LAVI E WEISS SR PATERSON Y
Citation: Rm. Sutherland et al., CD4(-CELLS ARE NOT MAJOR EFFECTORS OF MOUSE HEPATITIS-VIRUS A59-INDUCED DEMYELINATING DISEASE() AND CD8(+) T), Journal of neurovirology, 3(3), 1997, pp. 225-228

Authors: MANFREDONIA DJ ABBOTT TA WEISS SR SHERMAN L BOLOGNESE MA BOLOGNESE CJ FULLER JL BERGER ML
Citation: Dj. Manfredonia et al., THE IMPACT OF OSTEOPOROSIS SCREENING AND EDUCATION-PROGRAMS ON PATIENT BEHAVIOR, DIAGNOSIS AND TREATMENT, Journal of bone and mineral research, 12, 1997, pp. 299-299

Authors: WEISS SR KNOPP R DAVIDSON M STEIN EA LASKARZEWSKI P ILLINGWORTH DR DUJOVNE C HUNNINGHAKE D MELINO MR MITCHEL YB
Citation: Sr. Weiss et al., EXPANDED DOSES OF SIMVASTATIN - EFFICACY AND SAFETY OF 80 AND 160 MG IN HYPERCHOLESTEROLEMIA, Journal of the American College of Cardiology, 29(2), 1997, pp. 8064-8064

Authors: BAPTISTA T DEBAPTISTA EA HERNANDEZ L ALTEMUS M WEISS SR
Citation: T. Baptista et al., TAMOXIFEN PREVENTS SULPIRIDE-INDUCED WEIGHT-GAIN IN FEMALE RATS, Pharmacology, biochemistry and behavior, 57(1-2), 1997, pp. 215-222

Authors: LEPARCGOFFART I HINGLEY ST CHUA MM JIANG XH LAVI E WEISS SR
Citation: I. Leparcgoffart et al., ALTERED PATHOGENESIS OF A MUTANT OF THE MURINE CORONAVIRUS MHV-A59 ISASSOCIATED WITH A Q159L AMINO-ACID SUBSTITUTION IN THE SPIKE PROTEIN, Virology, 239(1), 1997, pp. 1-10

Authors: PINON JD MAYREDDY RR TURNER JD KHAN FS BONILLA PJ WEISS SR
Citation: Jd. Pinon et al., EFFICIENT AUTOPROTEOLYTIC PROCESSING OF THE MHV-A59 3C-LIKE PROTEINASE FROM THE FLANKING HYDROPHOBIC DOMAINS REQUIRES MEMBRANES, Virology, 230(2), 1997, pp. 309-322

Authors: BONILLA PJ HUGHES SA WEISS SR
Citation: Pj. Bonilla et al., CHARACTERIZATION OF A 2ND CLEAVAGE SITE AND DEMONSTRATION OF ACTIVITYIN TRANS BY THE PAPAIN-LIKE PROTEINASE OF THE MURINE CORONAVIRUS MOUSE HEPATITIS-VIRUS STRAIN A59, Journal of virology, 71(2), 1997, pp. 900-909

Authors: FISCHER F PENG D HINGLEY ST WEISS SR MASTERS PS
Citation: F. Fischer et al., THE INTERNAL OPEN READING FRAME WITHIN THE NUCLEOCAPSID GENE OF MOUSEHEPATITIS-VIRUS ENCODES A STRUCTURAL PROTEIN THAT IS NOT ESSENTIAL FOR VIRAL REPLICATION, Journal of virology, 71(2), 1997, pp. 996-1003

Authors: DAVIDSON MH NAWROCKI JW WEISS SR SCHWARTZ SL LUPIEN PJ JONES PH HABER HE BLACK DM
Citation: Mh. Davidson et al., EFFECTIVENESS OF ATORVASTATIN FOR REDUCING LOW-DENSITY-LIPOPROTEIN CHOLESTEROL TO NATIONAL CHOLESTEROL EDUCATION-PROGRAM TREATMENT GOALS, The American journal of cardiology, 80(3), 1997, pp. 347

Authors: DAVIDSON MH STEIN EA DUJOVNE CA HUNNINGHAKE DB WEISS SR KNOPP RH ILLINGWORTH DR MITCHEL YB MELINO MR ZUPKIS RV DOBRINSKA MR AMIN RD TOBERT JA
Citation: Mh. Davidson et al., THE EFFICACY AND 6-WEEK TOLERABILITY OF SIMVASTATIN 80 AND 160 MG DAY/, The American journal of cardiology, 79(1), 1997, pp. 38-42

Authors: NAWROCKI JW WEISS SR DAVIDSON MH SPRECHER DL SCHWARTZ SL LUPIEN PJ JONES PH HABER HE BLACK DM
Citation: Jw. Nawrocki et al., REDUCTION OF LDL CHOLESTEROL BY 25-PERCEN T TO 60-PERCENT IN PATIENTSWITH PRIMARY HYPERCHOLESTEROLEMIA BY ATORVASTATIN, A NEW HMG-COA REDUCTASE INHIBITOR, Perfusion, 9(3), 1996, pp. 109-114

Authors: BRAMBILLA DJ MCKINLAY SM MCKINLAY JB WEISS SR JOHANNES CB CRAWFORD SL LONGCOPE C
Citation: Dj. Brambilla et al., DOES COLLECTING REPEATED BLOOD-SAMPLES FROM EACH SUBJECT IMPROVE THE PRECISION OF ESTIMATED STEROID-HORMONE LEVELS, Journal of clinical epidemiology, 49(3), 1996, pp. 345-350

Authors: MANFREDONIA DJ WEISS SR BOLOGNESE MA ABBOTT TA STEVER GJ BOLOGNESE CJ FREINBERG SL FULLER JL BERGER ML
Citation: Dj. Manfredonia et al., THE PREVALENCE OF OSTEOPOROSIS AND OSTEOPENIA AMONG WOMEN - AN ANALYSIS OF 2 CONVENIENCE POPULATIONS, Journal of bone and mineral research, 11, 1996, pp. 586-586

Authors: HEINONEN TM STEIN E WEISS SR MCKENNEY JM DAVIDSON M SHURZINSKE L BLACK DM
Citation: Tm. Heinonen et al., THE LIPID-LOWERING EFFECTS OF ATORVASTATIN, A NEW HMG-COA REDUCTASE INHIBITOR - RESULTS OF A RANDOMIZED, DOUBLE-MASKED STUDY, Clinical therapeutics, 18(5), 1996, pp. 853-863

Authors: BAKKERARKEMA RG DAVIDSON MH GOLDSTEIN RJ DAVIGNON J ISAACSOHN JL WEISS SR KEILSON LM BROWN WV MILLER VT SHURZINSKE LJ BLACK DM
Citation: Rg. Bakkerarkema et al., EFFICACY AND SAFETY OF A NEW HMG-COA REDUCTASE INHIBITOR, ATORVASTATIN, IN PATIENTS WITH HYPERTRIGLYCERIDEMIA, JAMA, the journal of the American Medical Association, 275(2), 1996, pp. 128-133

Authors: LAVI E WANG Q WEISS SR GONATAS NK
Citation: E. Lavi et al., SYNCYTIA FORMATION INDUCED BY CORONAVIRUS INFECTION IS ASSOCIATED WITH FRAGMENTATION AND REARRANGEMENT OF THE GOLGI-APPARATUS, Virology, 221(2), 1996, pp. 325-334

Authors: LIBERMAN UA WEISS SR BROLL J
Citation: Ua. Liberman et al., EFFECT OF ORAL ALENDRONATE ON BONE-MINERAL DENSITY AND THE INCIDENCE OF FRACTURES IN POSTMENOPAUSAL OSTEOPOROSIS (VOL 333, PG 1437, 1995), The New England journal of medicine, 334(11), 1996, pp. 734-735
Risultati: 1-25 | 26-40